Skip to content
Screener

Omnicell OMCL Treasury Stock

Treasury Stock at other companies

Baxter International logo
Baxter InternationalBAX
$10.74B-1.8%
Cardinal Health, Inc. logo
Cardinal Health, Inc.CAH
$7.61B+19.6%
ICU Medical logo
ICU MedicalICUI
$23.42M+390,150%
Cencora logo
CencoraCOR
$11.45B+10.8%
Solventum logo
SolventumSOLV
$355M
LifeMD, Inc. logo
LifeMD, Inc.LFMD
$163.7K0.0%

Other financials

Income statement

See full
Revenue$312.2M+7.4%
Gross profit$152.9M+19.8%
Operating income$32.4M+300%
Net income$24.3M+331%
EPS (diluted)$0.52+333%

Balance sheet

See full
Cash & equivalents$322.8M-25.2%
Total debt$31.8M-25.4%
Total equity$1.3B+2.2%
Total assets$2.0B-6.8%

Cash flow

See full
Operating cash flow$68.3M+59.8%
CapEx$8.9M-24.1%
Free cash flow$59.4M+91.7%

Valuation

See full
Market cap$1.68B+18.6%
Enterprise value$1.39B+35.1%
P/E35.9×
P/S1.4×+0.1×

Profitability

See full
Gross margin44.8%+1.0pp
Operating margin4.6%+3.3pp
Net margin1.7%+1.1pp
FCF margin11.4%+2.1pp

Returns & leverage

See full
Return on equity1.6%+1.1pp
Debt / equity0.0×
Current ratio1.6×+0.2×

Where this comes from

Reported directly by Omnicell in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonValue.

The source filing: Omnicell’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:09 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000926326-26-000022
Line itemJune 30,2026December 31,2025
Stockholders’ equity:
Preferred stock, $0.001 par value, 5,000 shares authorized; no shares issued
Common stock, $0.001 par value, 100,000 shares authorized; 58,419 and 57,833 shares issued; 45,613 and 45,027 shares outstanding, respectively5858
Treasury stock at cost, 12,806 shares outstanding(368,307)(368,307)
Additional paid-in capital1,250,3821,223,977
Retained earnings420,587384,940
Accumulated other comprehensive loss(11,115)(8,854)
Total stockholders’ equity1,291,6051,231,814

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is Omnicell's treasury stock?
Omnicell (OMCL) reported treasury stock of $368.31M in Q2 2026.
How has Omnicell's treasury stock changed year-over-year?
Omnicell's treasury stock increased by 20.4% year-over-year, from $305.97M to $368.31M.
What is the long-term trend for Omnicell's treasury stock?
Over 5 years (2020 to 2025), Omnicell's treasury stock has grown at a 9.1% compound annual growth rate (CAGR), from $238.11M to $368.31M.
What does treasury stock mean?
Shares repurchased by the company and held in treasury, reducing equity. Recorded at cost and presented as a negative equity component.

Ask your AI about Omnicell's treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude